[HTML][HTML] Genetic architecture of the acute and persistent immune cell response after radiation exposure
L He, C Zhong, H Chang, JL Inman, SE Celniker… - Cell Genomics, 2023 - cell.com
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
Genetic architecture of the acute and persistent immune cell response after radiation exposure
L He, C Zhong, H Chang, J Inman, S Celniker… - Cell Genomics, 2023 - europepmc.org
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
Genetic architecture of the acute and persistent immune cell response after radiation exposure
L He, C Zhong, H Chang, JL Inman… - Cell …, 2023 - pubmed.ncbi.nlm.nih.gov
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
[HTML][HTML] Genetic architecture of the acute and persistent immune cell response after radiation exposure
L He, C Zhong, H Chang, JL Inman, SE Celniker… - Cell …, 2023 - ncbi.nlm.nih.gov
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
Genetic architecture of the acute and persistent immune cell response after radiation exposure.
A Snijders, L He, C Zhong, H Chang, J Inman… - Cell …, 2023 - escholarship.org
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
[HTML][HTML] Genetic architecture of the acute and persistent immune cell response after radiation exposure
L He, C Zhong, H Chang, JL Inman, SE Celniker… - Cell Genomics, 2023 - Elsevier
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
Genetic architecture of the acute and persistent immune cell response after radiation exposure.
L He, C Zhong, H Chang, JL Inman, SE Celniker… - Cell Genomics, 2023 - europepmc.org
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …
studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred …